Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).

Pérez de Isla L, Alonso R, Mata N, Saltijeral A, Muñiz O, Rubio-Marin P, Diaz-Diaz JL, Fuentes F, de Andrés R, Zambón D, Galiana J, Piedecausa M, Aguado R, Mosquera D, Vidal JI, Ruiz E, Manjón L, Mauri M, Padró T, Miramontes JP, Mata P; SAFEHEART Investigators.

Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):2004-10. doi: 10.1161/ATVBAHA.116.307514. Epub 2016 Jul 21.

PMID:
27444203
2.

Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up.

Perez de Isla L, Alonso R, Watts GF, Mata N, Saltijeral Cerezo A, Muñiz O, Fuentes F, Diaz-Diaz JL, de Andrés R, Zambón D, Rubio-Marin P, Barba-Romero MA, Saenz P, Sanchez Muñoz-Torrero JF, Martinez-Faedo C, Miramontes-Gonzalez JP, Badimón L, Mata P; SAFEHEART Investigators.

J Am Coll Cardiol. 2016 Mar 22;67(11):1278-85. doi: 10.1016/j.jacc.2016.01.008.

3.

Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: The SAFEHEART study.

Fuentes F, Alcala-Diaz JF, Watts GF, Alonso R, Muñiz O, Díaz-Díaz JL, Mata N, Sanchez Muñoz-Torrero JF, Brea Á, Galiana J, Figueras R, Aguado R, Piedecausa M, Cepeda JM, Vidal JI, Rodríguez-Cantalejo F, López-Miranda J, Mata P; SAFEHEART Investigators.

Int J Cardiol. 2015 Dec 15;201:79-84. doi: 10.1016/j.ijcard.2015.07.107. Epub 2015 Aug 5.

PMID:
26296047
4.

Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation.

Alonso R, Andres E, Mata N, Fuentes-Jiménez F, Badimón L, López-Miranda J, Padró T, Muñiz O, Díaz-Díaz JL, Mauri M, Ordovás JM, Mata P; SAFEHEART Investigators.

J Am Coll Cardiol. 2014 May 20;63(19):1982-9. doi: 10.1016/j.jacc.2014.01.063. Epub 2014 Mar 13.

5.

Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART).

Mata N, Alonso R, Badimón L, Padró T, Fuentes F, Muñiz O, Perez-Jiménez F, López-Miranda J, Díaz JL, Vidal JI, Barba A, Piedecausa M, Sanchez JF, Irigoyen L, Guallar E, Ordovas JM, Mata P.

Lipids Health Dis. 2011 Jun 10;10:94. doi: 10.1186/1476-511X-10-94.

6.

Blood glucose control and quality of health care in non-insulin-treated patients with Type 2 diabetes in Spain: a retrospective and cross-sectional observational study.

Rodríguez A, Calle A, Vázquez L, Chacón F, Polavieja P, Reviriego J; CADiNI Study Group.

Diabet Med. 2011 Jun;28(6):731-40. doi: 10.1111/j.1464-5491.2011.03258.x.

7.

Evidence for an electrogenic, negatively protein-kinase-A-modulated, Na+-dependent HCO3- transporter in human lymphocytes.

de la Rosa LA, Cabado AG, Botana MA, Vieytes MR, Vidal JI, Botana LM.

Pflugers Arch. 1999 May;437(6):935-43.

PMID:
10370073
8.

[Seronegative systemic lupus erythematosus and autoimmune thyroiditis].

González-Gay MA, Cereijo MJ, Agüero JJ, Alonso MD, Fernández Sueiro JL, Vidal JI.

An Med Interna. 1993 Aug;10(8):393-4. Spanish.

PMID:
8218785
9.

[Different etiology of thyrotoxicosis as a function of previous prevalence of goiter].

Cordido F, Vidal JI, Valiño D, Tuñez F, Maíz D, Jorge S, Vidal O.

Med Clin (Barc). 1992 Jun 27;99(5):175-8. Spanish.

PMID:
1507896
10.

Study of insulin-like growth factor I in human obesity.

Cordido F, Casanueva FF, Vidal JI, Dieguez C.

Horm Res. 1991;36(5-6):187-91.

PMID:
1823077
11.

[Levels of beta-thromboglobulin in type I diabetes mellitus. Effect of dipyridamole].

Amado JA, Suárez M, Vadillo V, Vidal JI, Mazo E.

Rev Clin Esp. 1983 Sep 30;170(6):283-5. Spanish. No abstract available.

PMID:
6197727
12.

[Lipid profile in diabetes mellitus. Correlation with Hb A1].

Vidal JI, Vadillo V, Alvarez MC, Amado JA.

Rev Clin Esp. 1983 Mar 15;168(5):315-8. Spanish. No abstract available.

PMID:
6346411
13.

[Mechanisms responsible for hyperfibrinogenaemia in the diabetics ].

Amado JA, Sedano MC, Mazo E, Vadillo V, Vidal JI.

Sangre (Barc). 1982;27(2):145-9. Spanish. No abstract available.

PMID:
7123434

Supplemental Content

Loading ...
Support Center